A synthetic, soft tissue retina developed by an Oxford University doctoral chemistry student could offer fresh hope for visually impaired people.

PodcastsResourcesAnatomyEyeMedicine, Diagnosis, and TherapeuticsSense organsTissues
Previous articleBMS, Advaxis, Array Ink Independent Deals to Evaluate Combo Cancer Therapies
Next articleImmunoGen Licenses Cancer Compounds to Sanofi
Also of Interest
Visual Proteomics: Observing Protein Location in Living Cells
Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
New Insights Could Boost Immunotherapy for Rare Eye Cancer
Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders
StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline
Related Media
Carl Icahn States His Case for Change at Illumina on "Close to the Edge"
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Breathing Oxygen Back into the Biological Conversation
Global Single-Use Network Support Assurance of Supply
Resins Address Downstream Purification Concerns
Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies